Biologic Scaffolds
Author(s) -
Alessandra Costa,
Juan Diego Naranjo,
Ricardo Londoño,
Stephen F. Badylak
Publication year - 2017
Publication title -
cold spring harbor perspectives in medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.853
H-Index - 105
eISSN - 2472-5412
pISSN - 2157-1422
DOI - 10.1101/cshperspect.a025676
Subject(s) - scaffold , extracellular matrix , microbiology and biotechnology , progenitor cell , innate immune system , chemistry , macrophage , tissue engineering , stem cell , immune system , in vitro , biology , immunology , medicine , biomedical engineering , biochemistry
Biologic scaffold materials composed of allogeneic or xenogeneic extracellular matrix are commonly used for the repair and functional reconstruction of injured and missing tissues. These naturally occurring bioscaffolds are manufactured by the removal of the cellular content from source tissues while preserving the structural and functional molecular units of the remaining extracellular matrix (ECM). The mechanisms by which these bioscaffolds facilitate constructive remodeling and favorable clinical outcomes include release or creation of effector molecules that recruit endogenous stem/progenitor cells to the site of scaffold placement and modulation of the innate immune response, specifically the activation of an anti-inflammatory macrophage phenotype. The methods by which ECM biologic scaffolds are prepared, the current understanding of in vivo scaffold remodeling, and the associated clinical outcomes are discussed in this article.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom